APSA-02 is a biologic commercialized by Armata Pharmaceuticals, with a leading Phase II program in Bacteremia.

Wall Street analysts who follow Viking and Summit expect further gains in 2025. Quick gains are often lost on Wall Street, ...

India], December 13: Merck Foundation, the philanthropic arm of Merck KGaA Germany, in partnership with the African First Ladies, announced the winners of Merck Foundation's SONG Awards 2023 under two ...

The high-profile tenant is the latest to sign on at the former Merck campus, following Revlon's decision to move its R&D ...

Shares of Merck & Co. Inc. MRK inched 0.74% higher to $102.00 Friday, on what proved to be an all-around mixed trading ...

At least 29 patent suits were filed in the District of New Jersey in November, reflecting a jump from the rate of 18 suits ...

A review found half of the drugs studied had price increases based on new evidence of benefits, while the other half did not.

Chinese biotech firms are emerging in a highly resource-intensive and time-consuming scientific innovation endeavor drug discovery One of the latest ...

Page Valley News (PageValleyNews.com) is an online local news site and an independent, locally owned community website ...

EU regulators recommend approval of Merck's drug Welireg for certain patients with VHL disease or advanced kidney cancer.

Merck & Co.’s kidney cancer drug Welireg, Bayer and BridgeBio’s transthyretin amyloid cardiomyopathy (ATTR-CM) therapy, and ...